Your browser doesn't support javascript.
loading
The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir.
Wohl, D A; Bhatti, L; Small, C B; Edelstein, H; Zhao, H H; Margolis, D A; DeJesus, E; Weinberg, W G; Ross, L L; Shaefer, M S.
  • Wohl DA; AIDS Clinical Trials Unit, University of North Carolina, Chapel Hill, NC, USA.
  • Bhatti L; AIDS Healthcare Foundation, Beverly Hills, CA, USA.
  • Small CB; New York Medical College, Valhalla, NY, USA.
  • Edelstein H; Alameda County Medical Center, Oakland, CA, USA.
  • Zhao HH; GlaxoSmithKline, Research Triangle Park, Research Triangle Park, NC, USA.
  • Margolis DA; GlaxoSmithKline, Research Triangle Park, Research Triangle Park, NC, USA.
  • DeJesus E; Orlando Immunology Center, Orlando, FL, USA.
  • Weinberg WG; Kaiser Foundation Health Plan of Georgia, Inc., Atlanta, GA, USA.
  • Ross LL; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Shaefer MS; ViiV Healthcare, Research Triangle Park, NC, USA.
HIV Med ; 17(2): 106-17, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26176344
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ARN Viral / Didesoxinucleósidos / Densidad Ósea / Infecciones por VIH / Ritonavir / Lamivudine / Fármacos Anti-VIH / Sulfato de Atazanavir / Riñón / Lípidos Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ARN Viral / Didesoxinucleósidos / Densidad Ósea / Infecciones por VIH / Ritonavir / Lamivudine / Fármacos Anti-VIH / Sulfato de Atazanavir / Riñón / Lípidos Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article